Literature DB >> 8011193

Results of day-case surgery for lumbar disc prolapse.

A Kelly1, H Griffith, A Jamjoom.   

Abstract

Microdiscectomy for lumbar disc prolapse on a day-patient basis was introduced by our department in 1985 and first reported in 1987, but has not been generally adopted in the United Kingdom. We now report our experience of the first 100 patients with lumbar disc prolapse treated by day-case microdiscectomy. Post-operative assessment was in the out-patient clinic and by subsequent postal questionnaire (average follow-up 37 months, range 3-64 months). Complications were few and are described. Only three patients developed a recurrent disc prolapse. Patient feedback was favourable and the majority (85%) said that, if necessary, they would be prepared to have the operation again on a day-case basis. For selected patients, lumbar microdiscectomy is a suitable procedure for day-case surgery.

Entities:  

Mesh:

Year:  1994        PMID: 8011193     DOI: 10.3109/02688699409002392

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  4 in total

Review 1.  Safety of outpatient anterior cervical discectomy and fusion: a systematic review and meta-analysis.

Authors:  Dexiang Ban; Yang Liu; Taiwei Cao; Shiqing Feng
Journal:  Eur J Med Res       Date:  2016-08-31       Impact factor: 2.175

2.  Feasibility and Safety of Outpatient Lumbar Microscopic Discectomy in a Developing Country.

Authors:  Ashish Jaiswal; Satish Kumar; Siva Reddy; Parineeta Jaiswal
Journal:  Asian Spine J       Date:  2019-06-03

3.  Comparison of inpatient vs. outpatient anterior cervical discectomy and fusion: a retrospective case series.

Authors:  Jeffrey T Liu; Rudy P Briner; Jonathan A Friedman
Journal:  BMC Surg       Date:  2009-03-05       Impact factor: 2.102

4.  Lumbar microdiscectomy and post-operative activity restrictions: a protocol for a single blinded randomised controlled trial.

Authors:  Chris D Daly; Kai Zheong Lim; Jennifer Lewis; Kelly Saber; Mohammed Molla; Naor Bar-Zeev; Tony Goldschlager
Journal:  BMC Musculoskelet Disord       Date:  2017-07-20       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.